Eric K. Richfield

6.8k total citations
76 papers, 5.4k citations indexed

About

Eric K. Richfield is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Eric K. Richfield has authored 76 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cellular and Molecular Neuroscience, 30 papers in Molecular Biology and 26 papers in Neurology. Recurrent topics in Eric K. Richfield's work include Neuroscience and Neuropharmacology Research (22 papers), Parkinson's Disease Mechanisms and Treatments (21 papers) and Neurotransmitter Receptor Influence on Behavior (20 papers). Eric K. Richfield is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Parkinson's Disease Mechanisms and Treatments (21 papers) and Neurotransmitter Receptor Influence on Behavior (20 papers). Eric K. Richfield collaborates with scholars based in United States, Netherlands and Austria. Eric K. Richfield's co-authors include Mona Thiruchelvam, Deborah A. Cory‐Slechta, Miles Herkenham, Raymond B. Baggs, John B. Penney, John B. Penney, Anne B. Young, A. Byron Young, Brian R. de Costa and A. William Tank and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and Blood.

In The Last Decade

Eric K. Richfield

76 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric K. Richfield United States	41	3.0k	1.9k	1.8k	660	545	76	5.4k
Rita Raisman‐Vozari France	42	3.0k 1.0×	2.2k 1.2×	1.6k 0.9×	480 0.7×	188 0.3×	141	6.2k
Giambattista Bonanno Italy	45	3.4k 1.1×	836 0.4×	3.1k 1.8×	529 0.8×	155 0.3×	204	6.8k
Fabio Fumagalli Italy	43	4.1k 1.4×	631 0.3×	2.3k 1.3×	523 0.8×	164 0.3×	175	6.5k
Dwight C. German United States	47	3.3k 1.1×	1.8k 1.0×	1.7k 1.0×	420 0.6×	168 0.3×	94	6.9k
Richard M. Kostrzewa United States	35	2.5k 0.8×	774 0.4×	1.5k 0.9×	196 0.3×	124 0.2×	191	4.9k
G. Meco Italy	42	2.4k 0.8×	4.7k 2.5×	1.6k 0.9×	274 0.4×	196 0.4×	122	6.7k
Henry J. Waldvogel New Zealand	54	4.1k 1.4×	2.1k 1.1×	3.5k 1.9×	323 0.5×	179 0.3×	157	8.0k
Nobuyoshi Nishiyama Japan	39	1.9k 0.6×	270 0.1×	1.6k 0.9×	306 0.5×	427 0.8×	131	4.6k
Warren D. Hirst United States	46	2.5k 0.8×	1.8k 1.0×	2.5k 1.4×	475 0.7×	86 0.2×	90	5.9k
I J Kopin United States	34	2.1k 0.7×	793 0.4×	1.1k 0.6×	227 0.3×	138 0.3×	70	4.2k

Countries citing papers authored by Eric K. Richfield

Since Specialization

Citations

This map shows the geographic impact of Eric K. Richfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric K. Richfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric K. Richfield more than expected).

Fields of papers citing papers by Eric K. Richfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric K. Richfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric K. Richfield. The network helps show where Eric K. Richfield may publish in the future.

Co-authorship network of co-authors of Eric K. Richfield

This figure shows the co-authorship network connecting the top 25 collaborators of Eric K. Richfield. A scholar is included among the top collaborators of Eric K. Richfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric K. Richfield. Eric K. Richfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richfield, Eric K., et al.. (2016). Acromegaly Occurring In A Patient With A Pituitary Adenoma, Lymphocytic Hypophysitis, And A Rathke Cleft Cyst. AACE Clinical Case Reports. 3(2). e121–e125. 1 indexed citations

Scholze, Petra, Michael L. Berger, Harald Reither, et al.. (2011). Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience. 180. 280–292. 40 indexed citations

Prasad, Kavita, Pamela Ohman‐Strickland, Michael J. O’Neill, et al.. (2011). Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background. European Journal of Neuroscience. 33(4). 642–656. 18 indexed citations

Nicholas, Adeline K., João Pedro de Magalhães, Yevgenya Kraytsberg, et al.. (2010). Age-related gene-specific changes of A-to-I mRNA editing in the human brain. Mechanisms of Ageing and Development. 131(6). 445–447. 41 indexed citations

Cory‐Slechta, Deborah A., et al.. (2007). The gestational environment and Parkinson's disease: Evidence for neurodevelopmental origins of a neurodegenerative disorder. Reproductive Toxicology. 23(3). 457–470. 138 indexed citations

Chen, Li, Mona Thiruchelvam, Kiran Madura, & Eric K. Richfield. (2006). Proteasome dysfunction in aged human α-synuclein transgenic mice. Neurobiology of Disease. 23(1). 120–126. 71 indexed citations

Blackshear, Perry J., et al.. (2005). Zfp36l3, a Rodent X Chromosome Gene Encoding a Placenta-Specific Member of the Tristetraprolin Family of CCCH Tandem Zinc Finger Proteins. Biology of Reproduction. 73(2). 297–307. 77 indexed citations

Cory‐Slechta, Deborah A., et al.. (2005). Developmental Pesticide Models of the Parkinson Disease Phenotype. Environmental Health Perspectives. 113(9). 1263–1270. 97 indexed citations

Cory‐Slechta, Deborah A., et al.. (2005). Developmental pesticide exposures and the Parkinson's disease phenotype. Birth Defects Research Part A Clinical and Molecular Teratology. 73(3). 136–139. 42 indexed citations

10.

Mhyre, Timothy R., Elissa J. Chesler, Mona Thiruchelvam, et al.. (2004). Heritability, correlations and in silico mapping of locomotor behavior and neurochemistry in inbred strains of mice. Genes Brain & Behavior. 4(4). 209–228. 32 indexed citations

11.

Thiruchelvam, Mona, et al.. (2003). Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. Journal of Neurochemistry. 85(4). 1075–1086. 57 indexed citations

12.

Moritani, Toshio, et al.. (2003). Epidermal Nevus Syndrome: Megalencephaly with Bihemispheric and Cerebellar Involvement: Imaging and Neuropathologic Correlation. Journal of Computer Assisted Tomography. 27(4). 534–537. 17 indexed citations

13.

Powers, James M., Christopher Cox, Eric K. Richfield, et al.. (2001). The Dorsal Root Ganglia in Adrenomyeloneuropathy: Neuronal Atrophy and Abnormal Mitochondria. Journal of Neuropathology & Experimental Neurology. 60(5). 493–501. 70 indexed citations

14.

Thiruchelvam, Mona, Becky Brockel, Eric K. Richfield, Raymond B. Baggs, & Deborah A. Cory‐Slechta. (2000). Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?. Brain Research. 873(2). 225–234. 240 indexed citations

15.

McCoy, Lance, Christopher Cox, & Eric K. Richfield. (1998). Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse. 28(3). 195–207. 24 indexed citations

16.

Vonkeman, Harald E., Pieter Voorn, Linda S. Brady, Henk W. Berendse, & Eric K. Richfield. (1996). Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]Bremazocine. The Journal of Comparative Neurology. 374(2). 223–229. 13 indexed citations

17.

Richfield, Eric K., et al.. (1996). Preferential Vulnerability of Nucleus Accumbens Dopamine Binding Sites to Low‐Level Lead Exposure: Time Course of Effects and Interactions with Chronic Dopamine Agonist Treatments. Journal of Neurochemistry. 67(4). 1540–1550. 55 indexed citations

18.

Richfield, Eric K., Kathleen A. Maguire‐Zeiss, Harald E. Vonkeman, & Pieter Voorn. (1995). Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Annals of Neurology. 38(6). 852–861. 116 indexed citations

19.

Richfield, Eric K., Christopher O’Brien, Thomas A. Eskin, & Ira Shoulson. (1991). Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neuroscience Letters. 132(1). 121–126. 76 indexed citations

20.

Richfield, Eric K., Anne B. Young, & John B. Penney. (1989). Comparative distributions of dopamine D‐1 and D‐2 receptors in the cerebral cortex of rats, cats, and monkeys. The Journal of Comparative Neurology. 286(4). 409–426. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact